Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pain pump after liver surgery fails to boost breathing muscle

NCT ID NCT02353702

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving continuous local anesthetic (ropivacaine) near the incision after liver surgery could improve diaphragm function and reduce lung complications. It planned to include 88 adults, but was terminated early after enrolling only 31. The main goal was to measure diaphragm strength using a sniff test. The study was stopped before completion, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

31 people

The number who actually took part.

Started

Jul 2014

Finished

Jun 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Surgical Indication for Upper abdominal surgery through subcostal incision * More than 18 years old , less than 80 years old * ASA score between 1 and 3 * Effective contraception for more than 3 months in women of childbearing age * Patients signed an informed consent * Affiliation to a social security regimen Exclusion Criteria: * BMI more than 30 kg/m2 * Nasal obstruction during inclusion * Preoperative treatment with morphine * Need for a postoperative nasogastric tube * Difficulty to understand the use of the PCA and/or the sniff-test * Impossibility to place the catheter in preperitoneal position * Pregnant women or breasting women * Patients under guardianship * Contraindication to use of ropivacaine * Inclusion in another clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hepatectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rouen University Hospital

    Rouen, 76031, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.